awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26851694-4D6C343A-FED6-4009-B17E-8247BE171898
Q26851694-4D6C343A-FED6-4009-B17E-8247BE171898
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26851694-4D6C343A-FED6-4009-B17E-8247BE171898
Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments
P2860
Q26851694-4D6C343A-FED6-4009-B17E-8247BE171898
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26851694-4D6C343A-FED6-4009-B17E-8247BE171898
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2b7f6d97d5b9c24d6716bf3b63bb0e1f2b5ca758
P2860
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.